News headlines about Spectranetics Corp (NASDAQ:SPNC) have trended somewhat positive on Saturday, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Spectranetics Corp earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 44.8356137603812 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Shares of Spectranetics Corp (NASDAQ SPNC) opened at 38.45 on Friday. The company’s 50-day moving average price is $37.28 and its 200-day moving average price is $30.10. Spectranetics Corp has a 52-week low of $19.80 and a 52-week high of $38.55.
Spectranetics Corp (NASDAQ:SPNC) last issued its quarterly earnings data on Thursday, August 3rd. The medical equipment provider reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.29. The business had revenue of $74.71 million during the quarter, compared to the consensus estimate of $73.82 million. Spectranetics Corp had a negative return on equity of 194.18% and a negative net margin of 32.93%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.35) EPS. Analysts forecast that Spectranetics Corp will post ($1.16) EPS for the current year.
Spectranetics Corp Company Profile
The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads.
What are top analysts saying about Spectranetics Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Spectranetics Corp and related companies.